https://pmc.ncbi.nlm.nih.gov/articles/PMC4074568/
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid...
Pharmacologic augmentation of endogenous cannabinoid (eCB) signaling is an emerging therapeutic approach for the treatment of a broad range of...
cox 2 inhibitionas a